GlucoTrack Inc
glucotrack.comWhat Do They Do?
Develops an implantable continuous blood glucose monitor for people with type one diabetes and people with type two diabetes who use insulin or are at risk of low blood sugar.
10-K for FY2025, filed Mar 30, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$3.8MView ↗
- ▼ −20% (Loss)
- vs −$4.8M in Q2 FY2025
Product focus
The earlier report described a non-invasive monitor and an implantable continuous monitor. The latest report focuses on the implantable monitor and says it stopped developing and commercializing the non-invasive product.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 30, 2026We are a medical device company focused on the design, development and commercialization of novel technologies for use by people with…View ↗
Who Do They Compete With?
Competes with Abbott, DexCom, Medtronic, and Senseonics Holdings
10-K for FY2025, filed Mar 30, 2026The market for CGM devices is intensely competitive, subject to rapid change and significantly affected by new product introductions. Three…View ↗
Loading...
